1. Propuestas para una adecuada recepción del derecho a acceder a tratamientos y medicamentos experimentales: caso Estados Unidos-Colombia.
- Author
-
Duque Giraldo, Mateo
- Subjects
- *
TAX exemption , *TAX credits , *DRUG approval , *BURDEN of proof , *DRUG accessibility - Abstract
This research paper puts forward a set of academic proposals for the Colombian health care system's adequate incorporation of the right to try experimental treatments conceived in the United States. It explains the differences between the Colombian and the American health models regarding access to non-conventional drugs. A comparative qualitative method is used, which, by contrasting, would provide solutions to incorporate the right appropriately into the national health model. The research concludes that, for the right to be adequately adopted, it is crucial to take out voluntary policies that ensure experimental treatments, introduce presumption of fact on patients' economic capacity to avoid shifting the burden of proof, eliminate medical committees for the approval of these drugs--notwithstanding the fact that physicians may consult their risks and benefits with other medical bodies--, and incentivize credits and tax exemptions for insurers and manufacturers. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF